In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia
about
Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100Human CYP7A1 deficiency: progress and enigmasMonogenic hypercholesterolemia: new insights in pathogenesis and treatmentThematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemiaApolipoprotein E competitively inhibits receptor-dependent low density lipoprotein uptake by the liver but has no effect on cholesterol absorption or synthesis in the mouse.Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.Genetic basis of lipoprotein disorders.Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor bindingLDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectivesHaplotype analysis of the human apolipoprotein B mutation associated with familial defective apolipoprotein B100Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse.Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.Soybean protein diet increases low density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients.Genetic influences on susceptibility to atherosclerosis in the young.Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein BNovel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.Using new tools to define the genetic underpinnings of risky traits associated with coronary artery disease: the SardiNIA study.Three-fold effect of lovastatin treatment on low density lipoprotein metabolism in subjects with hyperlipidemia: increase in receptor activity, decrease in apoB production, and decrease in particle affinity for the receptor. Results from a novel triProbing of the expression of the low-density lipoprotein receptor in vivo using an anti-receptor monoclonal antibody.Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptorHDL heterogeneity and atherosclerosis.The Spectrum of Familial Hypercholesterolemia (FH) in Saudi Arabia: Prime Time for Patient FH Registry.Interpreting the Mechanism of APOE (p.Leu167del) Mutation in the Incidence of Familial Hypercholesterolemia; An In-silico Approach.Evaluation of reported pathogenic variants and their frequencies in a Japanese population based on a whole-genome reference panel of 2049 individuals.
P2860
Q24316428-86BBA984-8531-4AB5-9F01-9F090AE05C6AQ24552727-D04B86AA-4965-4D03-BD8A-8396E284F1D2Q24672834-6C5FA4F3-E67A-462B-A117-92E9ED24B1EEQ28259861-5FBE1D1F-CB4B-4906-AC9C-309E5DC85CCAQ33685645-FA1A51F0-349F-4537-9228-7E544AE667CEQ33688317-C041F5FF-5000-44B0-96DC-48D65F7F44D5Q33847743-8BD4E1B0-F5FD-4533-917C-5F3528123ADBQ34350695-11335B71-A133-4310-9848-D62D0F0C4D5CQ34467839-2268B52B-1A94-4605-A3D1-4954571F5F0DQ35198304-E545355F-0441-4624-9454-06BE772A67B4Q35553097-8FD76DB5-D08D-486F-BBA2-5C3FD642ED49Q35553545-301566F2-EC3C-4CEB-AB77-F075EEE05F3DQ35582323-C7B2ED33-7D12-4F8C-B171-90A95A683934Q35658091-D607F90D-C782-4FE5-9A71-981F4F4886B8Q35696516-3F2FF07C-6C13-4E79-8383-96432DDD540AQ35830557-D2CE5575-A205-43A3-B542-86A1D51D29C1Q36754862-E40C04E8-0AD7-49CA-9A4B-B786C844477BQ36925157-126BD118-B8B4-46D5-8881-F5CC4C679F7DQ37347231-690D3024-A57F-42E0-B07E-7A12D49916F4Q37705070-5B2F4CB0-E013-49A3-9604-2F35A04DCD5FQ38332334-AA47A8AB-B636-49B6-80ED-D277974B4EA5Q38984149-3F248D0A-0B0D-4A42-859E-0904A27973ADQ41128681-516BB8C2-3FA1-412D-84D1-805F4118DF2CQ41467514-94D6D679-4AD1-4F74-BFDF-F0AB401CABFBQ47098616-1EF3940C-6711-486E-A203-D119E78A62D0Q47388249-D95B5065-40E3-487D-9DFB-C6FD75C2380B
P2860
In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia
description
1986 nî lūn-bûn
@nan
1986 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@ast
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@en
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@nl
type
label
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@ast
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@en
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@nl
prefLabel
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@ast
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@en
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@nl
P2860
P356
P1476
In vivo evidence for reduced b ...... moderate hypercholesterolemia
@en
P2093
P2860
P304
P356
10.1172/JCI112729
P407
P577
1986-11-01T00:00:00Z